Christine A. Poon - 23 Aug 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Christine A. Poon
Issuer symbol
REGN
Transactions as of
23 Aug 2023
Net transactions value
-$6,954,161
Form type
4
Filing time
25 Aug 2023, 16:02:34 UTC
Previous filing
13 Jul 2023
Next filing
18 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $3,360,668 +12,280 +603% $273.67 14,317 23 Aug 2023 Direct
transaction REGN Common Stock Sale $251,376 -300 -2.1% $837.92 14,017 23 Aug 2023 Direct F1
transaction REGN Common Stock Sale $1,675,523 -1,998 -14% $838.60 12,019 23 Aug 2023 Direct F2
transaction REGN Common Stock Sale $2,545,212 -3,032 -25% $839.45 8,987 23 Aug 2023 Direct F3
transaction REGN Common Stock Sale $5,422,192 -6,450 -72% $840.65 2,537 23 Aug 2023 Direct F4
transaction REGN Common Stock Sale $420,525 -500 -20% $841.05 2,037 23 Aug 2023 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -12,280 -100% $0.000000* 0 23 Aug 2023 Common Stock 12,280 $273.67 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents volume-weighted average price of sales of 300 shares of Company stock on August 23, 2023 at prices ranging from $837.83 to $837.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
F2 Represents volume-weighted average price of sales 1,998 shares of Company stock on August 23, 2023 at prices ranging from $838.02 to $838.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 3,032 shares of Company stock on August 23, 2023 at prices ranging from $839.01 to $839.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 6,450 shares of Company stock on August 23, 2023 at prices ranging from $840.01 to $840.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 500 shares of Company stock on August 23, 2023 at prices ranging from $841.02 to $841.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2023 at each separate price.
F6 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.